๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐-๐๐๐๐ - ๐๐จ๐ฌ๐ญ๐
๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ || 2024-2031
Angioplasty balloons are essential devices utilized in percutaneous transluminal angioplasty (PTA), a procedure primarily used to address cardiovascular conditions, particularly coronary artery disease. These balloons are instrumental in treating acute cardiac events such as heart attacks, where their timely deployment can help reopen blocked arteries, restore blood flow, and reduce heart muscle damage. The global growth of the angioplasty balloons market is propelled by the rising prevalence of cardiovascular diseases, an increasing preference for minimally invasive surgeries, and the growing geriatric population, which is more prone to heart-related issues.
๐๐๐ญ ๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ -https://www.datamintelligence.com/download-sample/angioplasty-balloons-market
๐๐๐ฒ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
โข On June 17, 2020, the U.S. Food and Drug Administration (FDA) approved the INFINITY Angioplasty Balloon platform, designed specifically for the treatment of peripheral artery disease (PAD) through percutaneous transluminal angioplasty (PTA). The innovative balloon platform was developed to enhance PAD therapy outcomes.
โข In November 2020, Infinity Angioplasty Balloon Co. announced the commercial availability of the Infinity Angioplasty Balloon Catheter, following the successful completion of a First-in-Human clinical trial. This marked a significant milestone in expanding treatment options for PAD patients.
๐๐๐ซ๐ค๐๐ญ ๐๐ฒ๐ง๐๐ฆ๐ข๐๐ฌ:
The global rise in cardiovascular diseases (CVD) presents a significant public health challenge, driven by multiple factors such as unhealthy diets, sedentary lifestyles, tobacco use, obesity, high blood pressure, high cholesterol levels, diabetes, and aging populations. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, responsible for an estimated 18 million deaths annually. This trend reflects the urgent need for preventive measures and treatments for cardiovascular conditions.
CVDs encompass various disorders of the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and rheumatic heart disease. Notably, heart attacks and strokes account for over 80% of CVD-related deaths, with one-third of these fatalities occurring in individuals under 70. Behavioral risk factors, including unhealthy eating, lack of physical activity, smoking, and excessive alcohol consumption, play a critical role in heart disease and stroke incidence. Consequently, the increasing prevalence of CVDs is a key driver of market growth in the healthcare sector, particularly for products and interventions aimed at treating and preventing these conditions.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
โก By Product Type: Drug Eluting Balloons, Normal Balloons, Cutting/Scoring Balloons.
โก By Application: Coronary Angioplasty, Peripheral Angioplasty.
โก By End-User: Hospitals, Ambulatory Surgical Centers, Others.
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.datamintelligence.com/customize/angioplasty-balloons-market
๐๐๐ฃ๐จ๐ซ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
โข Boston Scientific Corporation
โข BIOTRONIK
โข Medtronic Plc
โข Cordis (Cardinal Health)
โข Terumo Corporation
โข Abbott Laboratories
โข AngioDynamics
โข BD
โข INFINITY Angioplasty Balloon
โข Koninklijke Philips N.V.
*๐๐จ๐ญ๐:
**๐๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ฏ๐๐ซ๐ฌ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐๐ฌ ๐๐ง ๐ข๐ง-๐๐๐ฉ๐ญ๐ก ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐ ๐๐ฆ๐๐ซ๐ ๐ข๐ง๐ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐ง๐ ๐ฌ๐ญ๐๐ซ๐ญ๐ฎ๐ฉ๐ฌ, ๐ฐ๐ก๐ข๐๐ก ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ฏ๐๐ฅ๐ฎ๐๐๐ฅ๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ ๐๐ฏ๐จ๐ฅ๐ฏ๐ข๐ง๐ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฅ๐๐ง๐๐ฌ๐๐๐ฉ๐ ๐๐ง๐ ๐ค๐๐ฒ ๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐๐๐ข๐ง๐ ๐๐๐จ๐ฉ๐ญ๐๐**
๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Coronary Stents Market: https://datamintelligence.com/research-report/coronary-stents-market
Bare Metal Stents Market: https://datamintelligence.com/research-report/bare-metal-stents-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ๐๐ง๐ ๐ข๐จ๐ฉ๐ฅ๐๐ฌ๐ญ๐ฒ ๐๐๐ฅ๐ฅ๐จ๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ, ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค - ๐๐๐๐-๐๐๐๐ - ๐๐จ๐ฌ๐ญ๐ here
News-ID: 3656764 • Views: โฆ
More Releases from DataM Intelligence 4market Research LLP
Sustainable Aviation Fuel Report Analysis, Research Studies - 2024-2031 - Neste, โฆ
The Global Sustainable Aviation Fuel Market was valued at USD 320.8 million in 2023 and is projected to experience significant growth, reaching USD 3,581.0 million by 2031. This represents a robust CAGR of 35.2% during the forecast period 2024-2031.
Sustainable Aviation Fuel (SAF) is a type of aviation fuel derived from sustainable sources that aims to reduce the carbon footprint associated with traditional jet fuels. Unlike conventional fossil-based jet fuels, SAFโฆ
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ-๐๐๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐ โฆ
The global Treatment-Resistant Depression Market is projected to experience significant growth with a high CAGR during the forecast period (2024-2031).
Treatment-Resistant Depression (TRD) refers to a form of major depressive disorder (MDD) in which patients do not respond adequately to standard treatments, such as antidepressants or psychotherapy. Typically, a person is considered to have TRD when they have tried at least two different antidepressant medications, each for an adequate duration andโฆ
Cereal Market is projected to expand significantly, reaching an estimated USD 53 โฆ
The global cereals market was valued at USD 40.3 billion in 2022 and is anticipated to experience substantial growth, reaching approximately USD 53 billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031.
Cereal grains, including wheat, corn, rice, oats, and barley, are processed into various forms of cereals enjoyed globally. These cereals are essential sources of energy, carbohydrates, protein, and fiber, andโฆ
Soda Ash Market Report Analysis, Research Studies - 2024-2031 - CIECH SA, DWC Lt โฆ
The Global Soda Ash Market is projected to grow at a compound annual growth rate (CAGR) of 4.1 % during the forecast period from 2024 to 2031.
Soda ash, also known as anhydrous sodium carbonate, is a key industrial chemical with a wide range of applications. It is predominantly used in the manufacture of glass, where it acts as a flux to lower the melting point of silica. Soda ash isโฆ
More Releases for Angioplasty
Angioplasty Balloon Market is Fueled by Increasing of Demand for Angioplasty Bal โฆ
The Angioplasty Balloon Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/angioplasty-balloon-market/
Angioplasty balloon is used in various interventional procedures for the treatmentโฆ
Angioplasty Balloons Market Report Up to 2031
Visiongain has published a new report on Angioplasty Balloons Market Report to 2031: Forecasts By Product Type (Normal, Drug-Eluting, and Cutting & Scoring Balloons), By Application (Coronary Artery Disease and Peripheral Artery Diseases) PLUS COVID-19 Recovery Scenarios.
How has COVID-19 Impacted on Angioplasty Balloons Market
COVID-19 pandemic adversely affected over 200 countries worldwide. Companies have been pressured to upsurge production capacity and raise the supply of products and other commodities. The pandemicโฆ
Estimation: Angioplasty Balloons Market COVID-19 impact
The global angioplasty balloons market is estimated to surpass $3,043.8 million by 2027, exhibiting a CAGR of 3.3% from 2020 to 2027.
OFFERINGS OF THE REPORT:
The report offers comprehensive analysis of the global angioplasty balloons market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market.
The report also sheds light onโฆ
Angioplasty Balloons Market: Semi-compliant balloons to be the most preferred an โฆ
Balloon angioplasty is increasingly being used to carry out various specific tasks during surgeries, such as scoring, cutting, and drug eluting. Manufacturers of angioplasty balloons are focusing on improving patient outcomes by constantly upgrading their existing products. Balloon angioplasty is widely preferred for being minimally-invasive, and can be performed under local anaesthesia, wherein, the patient can be discharged within 24 hours after the surgery, in most cases. Moreover, drug-coated balloonโฆ
Angioplasty Balloons Market Opportunity Analysis, 2018-2026
Angioplasty balloon is a medical device that is used for surgical widening or unblocking of a blood vessel, especially a coronary artery. A noticeable increase in health conditions have been is observed due to some factors that cause heart related diseases such as obesity, poor diet, and extra cholesterol. .Coronary artery disease is a life threatening disease which occurs due to insufficient supply of blood to the heart, leading toโฆ
Angioplasty Balloons Market : Regional & Competitive Analysis
According to a TMR analyst, โThe global market for angioplasty balloons is likely to witness a 3.5% CAGR from 2015 to 2023. The market is expected to rise from a valuation of US$1.93 bn in 2016 and is anticipated to reach US$2.55 bn by 2023.โ The segment of normal balloons is anticipated to lead the global market for angioplasty balloons for the years to come. Nevertheless, the segment of drugโฆ